📰 Gene Therapy Program News
Page 7 - Gene Therapy Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gene Therapy Program. Real-time updates on events, politics, business and more.
October 24, 2022
- Taysha Gene Therapies is an emerging leader in the development of AAV gene therapies; new collaboration aimed at enhancing development of two of Tayshas...
October 20, 2022
Preclinical Data from iECURE’s GTP-506 Demonstrates Potential for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency
October 12, 2022
PHILADELPHIA, Oct. 10, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing...
October 10, 2022
PHILADELPHIA, Oct. 10, 2022 -- Passage Bio, Inc. , a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced... | October 10, 2022
September 13, 2022
The rapidly growing Philadelphia life sciences sector is hungry for lab and manufacturing space. Check out these Philly real estate projects.
August 11, 2022
11.08.2022 - TSHA-120 treated patients in GAN demonstrated durable improvement and recoverability of sensory nerve amplitude potential (SNAP), a definitive clinical endpoint, compared to natural history TSHA-120 commercial grade and clinical trial material ...
August 10, 2022
This past week in healthcare investigations
August 6, 2022
Passage Bio, Inc. (NASDAQ:NASDAQ:PASG) Q2 2022 Earnings Conference Call August 04, 2022, 08:30 AM ET Company Participants Stuart Henderson - VP of Corporate Development and IR Edgar Cale -...
August 5, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
July 6, 2022
06.07.2022 - President, Founder and Chief Executive Officer to participate in “AAV Gene Therapy: Delivery and Beyond” panel discussion on Wednesday, July 13, 2022 at 10:00 am ETDALLAS, July 06, 2022 (GLOBE NEWSWIRE) - Taysha Gene Therapies, Inc. (Nasdaq: ...